Life sciences · Preprint
arXiv · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Finding high-performing formulations is difficult when few have been measured and experimental budgets are limited. We propose KolTa, an active learning framework that selects batches to discover the top 5% of formulations at a target temperature under a fixed query budget. KolTa combines a three-stage predictor of component contributions, role-conditioned interactions, and anchored temperature response with task-specific soft physics constraints. Its Physics-Residual-Calibrated Upper Confidence Bound (PRC-UCB) acquisition rule combines predicted utility, ensemble disagreement, and a target-temperature physics residual, with nonnegative exploration weights fitted to out-of-fold signed errors. We evaluate the framework on three measured tasks and one simulated task covering binary-mixture viscosity, drug solubility, ionic-liquid viscosity, and electrolyte conductivity. KolTa ranks first or second in mean area under the learning curve (AULC) on every task and outperforms seven of the eight comparator strategies in paired tests, winning 75 of 78 paired comparisons across tasks and seeds against those seven strategies. Across the three measured tasks, its largest gap to the best mean AULC is 0.032, compared with at least 0.056 for every comparator. On Drug, reaching 80% average recovery of the remaining targets across drugs requires an estimated median of 348 additional formulation queries, about 18% fewer than the fastest comparator. Researchers can adapt the framework to diverse formulation problems through component roles and physical constraints.